Daxor Co. (NYSEAMERICAN:DXR – Get Free Report)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $12.67 and traded as low as $11.36. Daxor shares last traded at $11.45, with a volume of 1,139 shares.
Daxor Stock Down 1.6%
The stock has a fifty day moving average of $12.99 and a two-hundred day moving average of $12.67.
About Daxor
Daxor Corporation (NYSE American: DXR) is a medical technology company specializing in diagnostic solutions for the measurement of blood volume. The company’s proprietary BVA-100 and BVA-200 systems utilize radiolabeled albumin tracers to provide clinicians with precise determinations of total blood volume, plasma volume and red blood cell volume. By offering quantitative assessments rather than estimations, Daxor’s platform aims to improve clinical decision-making for conditions that involve fluid balance and hemodynamic status.
In addition to its analytical instruments, Daxor maintains a CLIA-certified laboratory service that processes in-vitro diagnostic reagents and delivers detailed blood volume reports directly to healthcare providers.
Further Reading
- Five stocks we like better than Daxor
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Daxor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daxor and related companies with MarketBeat.com's FREE daily email newsletter.
